Cargando…
Olanzapine with ondansetron and dexamethasone for the prevention of cisplatin-based chemotherapy-induced nausea and vomiting in lung cancer
Olanzapine is an atypical antipsychotic that has shown efficacy for the treatment of nausea, anxiety, and insomnia. This study was conducted to evaluate the efficacy of olanzapine (5 mg) combined with 5-HT3 receptor antagonists and dexamethasone for the prevention of chemotherapy-induced nausea and...
Autores principales: | Wang, Wenxian, Lou, Guangyuan, Zhang, Yiping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6156067/ https://www.ncbi.nlm.nih.gov/pubmed/30212982 http://dx.doi.org/10.1097/MD.0000000000012331 |
Ejemplares similares
-
Clinical research of Olanzapine for prevention of chemotherapy-induced nausea and vomiting
por: Tan, Lijun, et al.
Publicado: (2009) -
The Effect of Ondansetron and Dexamethasone on Nausea and Vomiting under Spinal Anesthesia
por: Kalani, Navid, et al.
Publicado: (2017) -
A Comparison of Preoperative Ondansetron and Dexamethasone in the Prevention of Post-Tympanoplasty Nausea and Vomiting
por: Eidi, Mahmoud, et al.
Publicado: (2012) -
The Effectiveness of Ondansetron and Dexamethasone in Preventing Postoperative Nausea and Vomiting After Laparoscopic Cholecystectomy
por: Qasemi, Farzad, et al.
Publicado: (2023) -
A meta-analysis of olanzapine for the prevention of chemotherapy-induced nausea and vomiting
por: Wang, Xiao-fei, et al.
Publicado: (2014)